Clerio is presently developing three products for the vision correction market: (i) a non-invasive, incision-free, tissue-sparing vision correction technology that modifies the refractive index of the cornea for the Intraocular Lens market, (ii) a premium contact lens targeted at an older demographic, and (iii) a non-invasive refractive surgery technology for the cornea that involves no cutting or ablation, distinguishing it from traditional LASIK surgery.